Hedera shows early signs of strength as a bullish RSI divergence emerges on the 4-hour chart, hinting at fading seller momentum after a steady decline.Hedera shows early signs of strength as a bullish RSI divergence emerges on the 4-hour chart, hinting at fading seller momentum after a steady decline.

Hedera Shows Bullish Divergence as ISO 20022 Catalyst Watch Intensifies

Analysts note growing interest in ISO 20022-aligned assets, including Hedera, as global payment upgrades near. Despite recent losses, stabilising price action and renewed accumulation signal improving sentiment across compliant digital-asset networks.

Bullish Divergence Appears on HBAR’s 4-Hour Chart

The 4-hour chart shows a clear bullish divergence forming between price and the Relative Strength Index. The asset recorded a lower low while the RSI produced a higher low during the same period. Analyst Chad noted that this pattern appears after an extended stretch of weakness that pushed the token from the mid-$0.15 region toward $0.13. The divergence suggests that selling pressure is slowing even though the price continued to edge downward.

HBARUSD Chart | Source:x

The signal emerges at a period when the market has shown persistent declines across multiple sessions. The RSI rebound from oversold territory reflects improving short-term momentum as sellers lose control of the market’s pace. While the price structure remains bearish, the momentum shift marks a technical development that traders often monitor during extended downturns. The divergence positions the altcoin for a possible relief move if buyers continue to re-enter around current support zones.

ISO 20022 Upgrade Draws Attention to Compliant Assets

Analyst Greeny noted that the approaching ISO 20022 upgrade is generating renewed market attention toward tokens already aligned with the standard. The list includes XRP, XLM, XDC, HBAR, ALGO, ICP, QNT, and IOTA. These assets continue to trade within tight ranges despite broader market weakness, showing compressed price action as global banks prepare for the latest phase of the messaging-standard transition.

HBAR Chart | Source:x

Greeny stated that the recent seven-day declines across the ISO-aligned group reflect macro pressures rather than changes within the networks themselves. These assets are positioned for interoperability as financial institutions move toward richer payment data formatting.

The analyst observed that past regulatory and system-upgrade periods frequently preceded corrective rebounds in the same group when liquidity remained thin and sentiment shifted toward caution. He added that remittance-focused assets such as XRP and XLM may receive additional attention as institutions integrate updated messaging frameworks.

Market Monitors Two-Day Window as Sentiment Stabilizes

Greeny said the next two days may serve as a stabilizing phase for ISO-aligned tokens after the recent pullback. Traders are watching whether these assets can maintain support levels following steep weekly drops. The analyst noted that ISO-ready networks often receive renewed institutional focus at the time of major infrastructure changes within the banking system. He explained that any rebound would be driven by their operational relevance rather than speculative momentum.

Hedera is included among the assets under observation during this period. The token remains within a broader downtrend yet continues to form technical signals that traders track closely. The combination of compressed trading ranges and the ongoing global transition to ISO 20022 creates a backdrop where compliant networks may regain attention once the system update moves into full effect.

Hedera Intraday Structure Shows Initial Stabilisation

The 24-hour chart recorded a steady decline from roughly $0.1485 toward a session low near $0.1388. The move formed a sequence of lower highs, reflecting continued selling early in the trading window. A midday liquidity sweep accelerated the drop, pushing the asset to its lowest level during the session as trading volume held near the $238 million mark.

HBARUSD 24-Hr Chart | Source: BraveNewCoin

Following the decline, the asset recovered part of the move, lifting back toward the $0.146 region. The rebound suggests a return of buyers at lower prices, limiting the downside extension. The recovery remains measured, indicating stabilisation rather than a complete reversal.

The price action continues to show cautious momentum, though the chart structure demonstrates that the market is absorbing earlier losses. Further recovery attempts would require sustained buying pressure through previous intraday resistance levels.

Market Opportunity
Bullish Degen Logo
Bullish Degen Price(BULLISH)
$0.01841
$0.01841$0.01841
+6.72%
USD
Bullish Degen (BULLISH) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Over $145M Evaporates In Brutal Long Squeeze

Over $145M Evaporates In Brutal Long Squeeze

The post Over $145M Evaporates In Brutal Long Squeeze appeared on BitcoinEthereumNews.com. Crypto Futures Liquidations: Over $145M Evaporates In Brutal Long Squeeze
Share
BitcoinEthereumNews2026/01/16 11:35
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Edges higher ahead of BoC-Fed policy outcome

Edges higher ahead of BoC-Fed policy outcome

The post Edges higher ahead of BoC-Fed policy outcome appeared on BitcoinEthereumNews.com. USD/CAD gains marginally to near 1.3760 ahead of monetary policy announcements by the Fed and the BoC. Both the Fed and the BoC are expected to lower interest rates. USD/CAD forms a Head and Shoulder chart pattern. The USD/CAD pair ticks up to near 1.3760 during the late European session on Wednesday. The Loonie pair gains marginally ahead of monetary policy outcomes by the Bank of Canada (BoC) and the Federal Reserve (Fed) during New York trading hours. Both the BoC and the Fed are expected to cut interest rates amid mounting labor market conditions in their respective economies. Inflationary pressures in the Canadian economy have cooled down, emerging as another reason behind the BoC’s dovish expectations. However, the Fed is expected to start the monetary-easing campaign despite the United States (US) inflation remaining higher. Investors will closely monitor press conferences from both Fed Chair Jerome Powell and BoC Governor Tiff Macklem to get cues about whether there will be more interest rate cuts in the remainder of the year. According to analysts from Barclays, the Fed’s latest median projections for interest rates are likely to call for three interest rate cuts by 2025. Ahead of the Fed’s monetary policy, the US Dollar Index (DXY), which tracks the Greenback’s value against six major currencies, holds onto Tuesday’s losses near 96.60. USD/CAD forms a Head and Shoulder chart pattern, which indicates a bearish reversal. The neckline of the above-mentioned chart pattern is plotted near 1.3715. The near-term trend of the pair remains bearish as it stays below the 20-day Exponential Moving Average (EMA), which trades around 1.3800. The 14-day Relative Strength Index (RSI) slides to near 40.00. A fresh bearish momentum would emerge if the RSI falls below that level. Going forward, the asset could slide towards the round level of…
Share
BitcoinEthereumNews2025/09/18 01:23